LONDON, March 30, 2015 /PRNewswire/ -- REPORT HIGHLIGHTS
The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019.
This report provides:
An overview of the global markets and technologies for cancer vaccines.
Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
Coverage of the cancer vaccines arena including diverse therapeutic platform technologies, immune-stimulating agents and approved vaccines for cancer.
Examination of the governmental and regulatory environment and how its effecting the market.
Information on new developments including products in Phase I-IV clinical trials, as well as new technologies.
Analysis of the market's dynamics, specifically growth and restriction factors, acquisitions and collaborations, and a look at the cancer vaccine market's current achievements and future challenges.
Relevant patent analysis, presented by year and by vaccine type.
SCOPE OF THE STUDY
The scope of this study entails the current the market for cancer vaccines, which includes therapeutic cancer vaccines and preventive cancer vaccines. Human papillomavirus (HPV) vaccines and hepatitis B vaccines are also included; however, while such vaccines only indirectly act against cancer, they do aid in reducing the global cancer burden. The report also includes regulatory aspects, current and developing technologies, the demographics of cancer incidence, innovation and challenges, patent analyses, market projections and market share, along with latest trends and clinical trials.
Sales data for the global and regional markets were corroborated for the present and forecasted values via statistical analysis. Product information and the technologies/platforms discussed in the report are based on their present and prospective application and practicality. The report presents sales analyses broken down geographically for the United States, Europe and the emerging markets. The emerging markets include countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand. The application of cancer vaccines in various types of cancer is discussed from both commercial perspective and that of a research and development (R&D) perspective.
Download the full report: https://www.reportbuyer.com/product/2559604/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article